Research Focus

Former Employee. MEDICINE; Research Stdy Asst II

Recent additions – View all

1. Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial

   Meeting Abstract

   Heist, R. S.; Gandhi, L.; Shapiro, G.; Rizvi, N. A.; Burris, H. A.; Bendell, J. C.; Baselga, J.; Yerganian, S. B.; Hsu, K.; Ogden, J.; more...
   Journal of Clinical Oncology (2013)

   Fulltext@MSK | Save